Red cell genotyping precision medicine: a conference summary
dc.contributor.author | Denomme, GA | |
dc.contributor.author | Anani, WQ | |
dc.contributor.author | Avent, Neil | |
dc.contributor.author | Bein, G | |
dc.contributor.author | Briggs, LB | |
dc.contributor.author | Lapadat, RC | |
dc.contributor.author | Montemayor, C | |
dc.contributor.author | Rios, M | |
dc.contributor.author | St-Louis, M | |
dc.contributor.author | Uhl, L | |
dc.contributor.author | Wendel, S | |
dc.contributor.author | Flegel, WA | |
dc.date.accessioned | 2017-11-27T13:56:01Z | |
dc.date.available | 2017-11-27T13:56:01Z | |
dc.date.issued | 2017-10 | |
dc.identifier.issn | 2040-6207 | |
dc.identifier.issn | 2040-6215 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/10282 | |
dc.description.abstract |
<jats:p>This review summarizes the salient points of the symposium ‘Red Cell Genotyping 2015: Precision Medicine’ held on 10 September 2015 in the Masur Auditorium of the National Institutes of Health. The specific aims of this 6th annual symposium were to: (1) discuss how advances in molecular immunohematology are changing patient care; (2) exemplify patient care strategies by case reports (clinical vignettes); (3) review the basic molecular studies and their current implications in clinical practice; (4) identify red cell genotyping strategies to prevent alloimmunization; and (5) compare and contrast future options of red cell genotyping in precision transfusion medicine. This symposium summary captured the state of the art of red cell genotyping and its contribution to the practice of precision medicine.</jats:p> | |
dc.format.extent | 277-291 | |
dc.format.medium | Print-Electronic | |
dc.language | en | |
dc.language.iso | en | |
dc.publisher | SAGE Publications | |
dc.subject | red cell genotyping | |
dc.subject | molecular immunohematology | |
dc.subject | transfusion precision medicine | |
dc.title | Red cell genotyping precision medicine: a conference summary | |
dc.type | journal-article | |
dc.type | Journal Article | |
dc.type | Review | |
plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412490000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
plymouth.issue | 10 | |
plymouth.volume | 8 | |
plymouth.publication-status | Published | |
plymouth.journal | Therapeutic Advances in Hematology | |
dc.identifier.doi | 10.1177/2040620717729128 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine/UoA01 Clinical Medicine | |
plymouth.organisational-group | /Plymouth/Research Groups | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED) | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR | |
dc.publisher.place | England | |
dcterms.dateAccepted | 2017-08-03 | |
dc.identifier.eissn | 2040-6215 | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.1177/2040620717729128 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2017-10 | |
rioxxterms.type | Journal Article/Review |